RDD Europe 2017 Scientific Program

Tuesday, April 25, 2017

5.00 p.m. -
7.30 p.m.

Registration

6.00 p.m. -
7.30 p.m.

Cocktail Reception

Wednesday, April 26, 2017

7.30 a.m.

Registration & Welcome Coffee

8.30 a.m.

Welcome Address & Introduction
Peter R. Byron, Ph.D.,
Emeritus Professor, School of Pharmacy,
Virginia Commonwealth University, Richmond, Virginia, USA

8.45 a.m.

PLENARY LECTURE: Patient Focused Device Design: Addressing Inhaler Technique and Improving Adherence
Federico Lavorini, M.D. Ph.D.,
Department of Experimental and Respiratory Medicine, Careggi University Hospital, Florence, Italy

9.30 a.m.

Refreshments, Scientific Poster Session & Technology Exhibition

Scientific Posters & Exhibit Tables will be available for viewing between 9.30 a.m. and 6.00 p.m.

10.00 a.m.

Session 1: Progress in Inhaled Drug Development

12.00 p.m.

Lunch, Scientific Poster Session & Technology Exhibition

2.00 p.m.

Session 2: Workshops

7.00 p.m. -
9.00 p.m.

AAPS Inhalation and Nasal Technology Focus Group

Thursday, April 27, 2017

7.30 a.m.

Registration & Welcome Coffee

8.30 a.m.

Scientific Poster Session & Technology Exhibition

Scientific Posters & Exhibit Tables will be available for viewing between 8.30 a.m. and 6.00 p.m.

8.30 a.m.

Session 3: Can Connected Devices Improve Respiratory Outcomes?

10.30 a.m.

Refreshments, Scientific Poster Session & Technology Exhibition

11.00 a.m.

Session 4: Posters on the Podium

12.00 p.m.

Lunch, Scientific Poster Session & Technology Exhibition

2.00 p.m.

Session 5: Changing Regulations in Europe

3.00 p.m.

Refreshments, Scientific Poster Session & Technology Exhibition

3.30 p.m.

Session 6: Achieving Deposition Equivalence

7.00 p.m.

Gala Dinner

Friday, April 28, 2017

7.30 a.m.

Registration & Welcome Coffee

8.30 a.m.

Scientific Poster Session & Technology Exhibition

Scientific Posters & Exhibit Tables will be available for viewing between 8.30 a.m. and 1.00 p.m.

8.30 a.m.

Session 7: Novel Approaches to Characterize Aerosol Dynamics

9.30 a.m.

Refreshments, Scientific Poster Session & Technology Exhibition

10.00 a.m.

Session 8: Designing Inhalation Products in a Quality by Design Era

12.00 p.m.

Lunch

2.00 p.m.

End of RDD Europe 2017

Wednesday, April 26, 2017

7.30 a.m.

Registration and Welcome Coffee

8.30 a.m.

Welcome Address & Introduction
Peter R. Byron, Ph.D.,
Emeritus Professor, School of Pharmacy,
Virginia Commonwealth University,
Richmond, Virginia, USA

8.45 a.m.

PLENARY LECTURE:

Sponsor:    Our Diamond and Gold Sponsors
Moderator: Peter R. Byron, Ph.D.

Patient Focused Device Design: Addressing Inhaler Technique and Improving Adherence
Federico Lavorini, M.D. Ph.D.,
Department of Experimental and Respiratory Medicine,
Careggi University Hospital, Florence, Italy

9.30 a.m.

Refreshments, Scientific Poster Session & Technology Exhibition

Sponsors:   3M Drug Delivery Systems and Catalent
Moderator: Richard N. Dalby, Ph.D. 

Scientific Posters & Exhibit Tables will be available for viewing between 9.30 a.m. and 6.00 p.m.

Session 1:

Progress in Inhaled Drug Development

Sponsor:    Vectura
Moderator: M. Geraldine Venthoye, Ph.D.

10.00 a.m.

Inhalation of Therapeutic Monoclonal Antibodies for Respiratory Diseases: Challenges and Opportunities
Nathalie Heuzé-Vourc’h, Ph.D,
INSERM U1100, Université de Tours, Tours, France

10.30 a.m.

Improving Asthma Rescue Treatment: Using Inhaled Corticosteroids to Enhance ß2-Adrenergic Bronchodilation
Adam Wanner, M.D.,
University of Miami, Miami, Florida, USA

11.00 a.m.

Pharmacokinetic Behavior of Fluticasone Propionate
and Salmeterol from Advair Diskus:
The Consequences of Batch Variability

Elise Burmeister Getz, Ph.D.,
Oriel Therapeutics, Berkeley, California, USA

11.30 a.m.

The Salford Lung Study: Rethinking Clinical Trial Design
by Assessing Effectiveness in Clinical Practice

Ashley Woodcock, M.D.,
University of Manchester, Manchester, United Kingdom

12.00 p.m.

Lunch, Scientific Poster Session & Technology Exhibition

Session 2

Workshops

Sponsor:    Aptar Pharma
Moderator: Gerallt Williams, Ph.D.

2.00 p.m. Workshop Selection #1
3.15 p.m. Workshop Selection #2
4.30 p.m. Workshop Selection #3

The following companies will each sponsor 60-minute interactive presentations on new technologies and services related to nasal and pulmonary drug delivery. Meeting participants may select and attend three of these sessions.

3M Drug Delivery Systems
The New Future - Introducing the Next Generation pMDI

Amcor
The Critical Role of Primary Packaging within the Qualification of Dry Powder Inhalers

Aptar Pharma & Propeller Health
Using Connected pMDIs to Monitor Inhaler Use and Drive Better Quality of Care

Capsugel
Engineered Particle Platform for Rapid Assessment of Inhaled Formulations: In Vitro and In Vivo Correlations

Centre of Postgraduate Medical Education (CMKP), Warsaw
Optimizing Dose Delivery of Nebulized Drugs

FLUIDDA
Functional Respiratory Imaging (FRI): Assessment of Lung Health to Optimize Respiratory Drug Delivery

H&T Presspart & Cohero Health
Smart Inhalers of the Future

Harro Höfliger Verpackungsmaschinen
Novel Inhaler for Controlled Pulmonary Delivery of Cannabis: Therapeutic and Technical Aspects

Hovione
Advanced Characterization and Design of Inhalable Formulations

Phillips-Medisize
Realizing the Benefits of Connected Health in Respiratory Drug Delivery

Proveris Scientific
Using a Novel Rapid Screening Technique to Streamline pMDI Formulation and Device Development

Qualicaps
Impact of Capsule Type on the Aerodynamic Performance of Dry Powder Formulations for Inhalation

6.00 p.m.

Workshop Sessions End

7.00 p.m.

AAPS Inhalation and Nasal Technology Focus Group

Thursday, April 27, 2017

7.30 a.m.

Registration and Welcome Coffee

8.30 a.m.

 

Scientific Poster Session & Technology Exhibition

Sponsors:   3M Drug Delivery Systems and Catalent
Moderator: Richard N. Dalby, Ph.D. 

Scientific Posters & Exhibit Tables will be available for viewing between 8.30 a.m. and 6.00 p.m.

Session 3:

Can Connected Devices Improve Respiratory Outcomes?

Sponsor:    H&T Presspart
Moderator: Stephen P. Stein, Ph.D.

8.30 a.m.

Connecting Professionals and Patients:  How Technology can Support Asthma Self-Management
Hilary Pinnock, M.D.,
University of Edinburgh, Edinburgh, United Kingdom

9.00 a.m.

Respiratory Acoustics: An Objective Assessment of Adherence to Inhalers in Patients with COPD
Richard W Costello, M.D.,
Royal College of Surgeons in Ireland, Dublin, Ireland

9.30 a.m.

‘Track and Remind’: Can Connected Devices Improve Patient Adherence?
Garth Sutherland, M.Sc., Adherium, Auckland, New Zealand

10.00 a.m.

Asthma Mobile Health Study: Engaging Patients in Asthma Self Management
Yu-Feng Y Chan, M.D. Ph.D.,
Icahn School of Medicine at Mount Sinai, New York, USA

10.30 a.m.

Refreshments, Scientific Poster Session & Technology Exhibition

Session 4:

Posters on the Podium

Sponsor:     MEGGLE
Moderators: Joanne Peart, Ph.D., and Paul M. Young, Ph.D.

11.00 a.m.

Posters on the Podium

Five poster authors will be selected to summarize their work and answer questions during a fast-paced interactive podium session.

11.05 a.m.

High-efficiency Delivery Of Aerosols Via An Infant Nasal Cannula
Susan Boc, B.Sc.
Virginia Commonwealth University, Richmond, Virginia, USA 

11.15 a.m.

Proof of Concept of the VITROCELL® Dry Powder Chamber: A New In Vitro Test System for the Controlled Deposition of Aerosol Formulations
Marius Hittinger, Ph.D.
PharmBio Tec, Saarbrücken, Germany 

11.25 a.m.

Validating a Realistic Physical Airway Model to Investigate In Vitro Drug Deposition, Dissolution, and Epithelial Transport of Orally Inhaled Products
Bao Huynh, B.Sc.
Woolcock Institute of Medical Research, Sydney, Australia 

11.35 a.m.

Comparison of Three Aqueous Aerosol Inhalation Devices for Delivering Anti-Tuberculosis Bacteriophage D29
Nicholas Carrigy, M.Eng.
University of Alberta, Edmonton, Alberta, Canada 

11.45 a.m.

 

Environmental Assessment of Metered Dose Inhaler Propellant: Potential For a Reduced Carbon Footprint Alternative
Adisa Azapagic, Ph.D.
University of Manchester, Manchester, United Kingdom 

12.00 p.m.

Presentation of VCU RDD Peter R. Byron Graduate Student Award

12.00 p.m.

Lunch, Scientific Poster Session & Technology Exhibition

Session 5

Changing Regulations in Europe

Sponsor:    Bespak
Moderator: John N. Pritchard, Ph.D.

2.00 p.m.

New European Medical Device Regulations: Implications for Orally Inhaled and Nasal Drug Products
Maria E. Donawa, M.D.,
Donawa Lifescience Consulting, Rome, Italy

2.30 p.m.

Licensing Medicines: Consequences of the UK “Brexit Vote” to leave the European Union
David Jefferys, M.D.,
Eisai Europe, Hatfield, United Kingdom

3.00 p.m.

Refreshments, Scientific Poster Session & Technology Exhibition

Session 6

Achieving Deposition Equivalence

Sponsor: Chiesi Farmaceutici
Chairman and Advocate: Peter R. Byron, Ph.D.

3.30 p.m.

Deposition Equivalence through DoE and Impaction Parameter Matching
Andrew R. Clark, Ph.D.,
Aerogen Pharma, San Mateo, California USA

3.50 p.m.

Flow Rate Dependence of Powder Inhalers: The Importance of the Q-Index
Jeffry Weers, Ph.D.,
Scientific Consultant, Half Moon Bay, California, USA

4.10 p.m.

Comparing Aerosol Capture in 8 Mouth-throat Models for a DPI, MDI and SMI
Dennis Sandell, Ph.D.,
S5 Consulting, Blentarp, Sweden

4.30 p.m.

Old Throats for New: A Curve Ball Posed by New USP Product Monographs
Jolyon P. Mitchell, Ph.D. (Delivered via Teleconference),
Scientific Consultant, London, Ontario, Canada

4.50 p.m.

Panel Discussion
Chairperson and Advocate: Peter R. Byron, Ph.D.
Virginia Commonwealth University, Richmond, Virginia, USA

Panel:
Elise Burmeister-Getz, Oriel Therapeutics
Andrew R. Clark, Aerogen Pharma
Jolyon P. Mitchell, Scientific Consultant
Dennis Sandell, S5 Consulting
Jeffry Weers, Novartis

5.30 p.m.

End of Discussion Forum

7.00 p.m.

Gala Dinner

Sponsored by Aptar Pharma

The Gala Dinner will be held at the Palm Beach, Cannes, famous for the International Film Festival, and will feature multicultural cuisine, entertainment, dancing and networking with other delegates.

Friday, April 28, 2017

7.30 a.m.

Registration and Welcome Coffee

8.30 a.m.

 

Scientific Poster Session & Technology Exhibition

Sponsors:   3M Drug Delivery Systems and Catalent
Moderator: Richard N. Dalby, Ph.D. 

Scientific Posters & Exhibit Tables will be available for viewing between 8.30 a.m. and 1.00 p.m.

Session 7:

Novel Approaches to Characterize Aerosol Dynamics

Sponsor:    Qualicaps
Moderator: Michael Hindle, Ph.D.

8.30 a.m.

Acini-on-Chip: Novel In Vitro Assessment of Particle Dynamics and Deposition in the Deep Lung
Josué Sznitman, Ph.D.,
Technion - Israel Institute of Technology, Haifa, Israel

9.00 a.m.

Using Phase Doppler Anemometry and High Speed Imaging to Analyze MDI Spray Plume Dynamics
Henk K. Versteeg, Ph.D.,
Loughborough University, Loughborough United Kingdom

9.30 a.m.

Refreshments, Scientific Poster Session & Technology Exhibition

Session 8:

Designing Inhalation Products in a Quality by Design Era

Sponsor:    Proveris Scientific
Moderator: Richard N. Dalby, Ph.D.

10.00 a.m.

HFA-philicity: Excipient Screening for pMDI Formulations
Sandro R. P. Da Rocha, Ph.D.,
Virginia Commonwealth University, Richmond, Virginia, USA

10.30 a.m.

Benchmarking Supercritical-CO2 assisted Spray Drying with Conventional Spray Drying for the Manufacture of Inhalation Formulations
Márcio Temtem, Ph.D.,
Hovione FarmaCiencia, Loures, Portugal

11.00 a.m.

Understanding Particle Formation Kinetics: Linking Device and Process with Particle Morphology and Product Performance
Reinhard Vehring, Ph.D.,
University of Alberta, Edmonton, Canada

11.30 a.m. Scientific and Regulatory Considerations on Particle Characterization and Specification Setting for Dry Powder Inhalers
Zhigang Sun, Ph.D. (Delivered via Teleconference),
Food and Drug Administration, Silver Spring, Maryland, USA

 

12.00 p.m.

Buffet Lunch provided

2.00 p.m.

End of RDD Europe 2017

Back to Top